Pharmacotherapy Home

Pharmacotherapy

Faculty

Photo

Knodel, Leroy C.,Pharm.D.
Assistant Division Head and
Clinical Professor/
Lonnie F. Hollingsworth Sr.
Centennial Fellow
of Pharmacotherapy
210- 567-8369
knodel@uthscsa.edu


Publications & Presentations

Clinical and Economic Considerations in the Use of COX-2 Specific Inhibitors@, Western Branches, Canadian Society of Health-System Pharmacists, 27th Annual Banff Seminar, Calgary, Alberta, Canada, March 17, 2001.

New Drugs of 2000,@ 49th Annual Postgraduate Pharmacy Seminar, The University of Texas at Austin College of Pharmacy, Austin, Texas, September 15, 2001.

Advances in Acid Suppression Therapy@, Annual Installation of Officers, Bexar County Pharmacy Association, San Antonio, Texas, February 8, 2001.

Evaluation of COX-1 and COX-2 Inhibitors@, Department of Defense Pharmacoeconomics/Pharmacy Benefit Conference, San Antonio, Texas, January 8, 2001.

The Pharmacodynamics of Proton Pump Inhibitors@, Houston Gastroenterology Summit, Houston, Texas, October 7, 2000.

Therapeutic Approaches in the Management of GERD: An Update,@ Central Texas Society of Hospital Pharmacists, San Antonio, Texas, August 8, 2000.

Cox-2 Technology: A Year in Review. The Promise and the Potential,@ Longs Drug Stores Pharmacy Managers Meeting 2000, Palm Springs, California, May 25, 2000.

Overview of the Pharmacology and GI Safety and Tolerability of COX-2 Inhibitors, @ Satellite Symposium entitled ACOX-2 Technology: A Year in Review. The Promise and the Potential, @ American Pharmaceutical Association Annual Meeting, Washington, D.C., March 13, 2000.

The Economic Burden of Arthritis and Cost Issues Related to the Use of COX-2 Inhibitors, @ Satellite Symposium entitled ACOX-2 Technology: A Year in Review. The Promise and the Potential, @ American Pharmaceutical Association Annual Meeting, Washington, D.C., March 13, 2000.

Knodel LC. Sexually transmitted diseases. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 4th edition. New York: Appleton & Lange, 1999.

Editor, Nonprescription Products: Formulations & Features '98-99. A Companion to the Handbook of Nonprescription Drugs (12th edition, 1998). Washington DC: American Pharmaceutical Association, 1998.

Seltzer JK, Kurt TL, Knodel LC, et al. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. J Am Pharm Assoc 2000;40:495-9.

Horton PM, Knodel LC. Dietary supplements containing ephedrine: Is a natural high a safe high? Toxic Substance Mechanisms 1998; 17:95-97.

Dugan DJ, Knodel LC. Alcohol and drugs: a potentially dangerous combination. Toxic Substance Mechanisms 1997;16:385-387.

Hatfield CL, Knodel LC, Talbert RL. Olestra: an ideal substitute for dietary fat? Toxic Substance Mechanisms 1997;16:209-11.

Knodel LC. Adverse health consequences of cigarette smoking also include drug interactions. Toxic Substance Mechanisms 1997;16:87-9.


More information about Dr. Knodel
> Return to Dr. Knodel's Home Page

Last Reviewed: June 4, 2008

Division Information

Mailing Address:
Pharmacotherapy
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX
78229-3900
USA

Email Address: pharmacy
@austin.utexas.edu

Phone:
1-210-567-8355


Reveles Traces Rate of Hospital Infections

Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.

Read more about Reveles' study.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z